Search research articles
Contact Us
Filters
Showing results (61-70 of 65) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 65 results.
The Canadian Journal of Cardiology
|
June 20, 2020
HEARTBiT: A Transcriptomic Signature for Excluding Acute Cellular Rejection in Adult Heart Allograft Patients
Casey P Shannon, Zsuzsanna Hollander, Darlene L Y Dai, et al.
The Canadian Journal of Cardiology
|
October 19, 2025
Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%)
Sean Virani, Shelley Zieroth, Natasha Aleksova, et al.
CJC Open
|
May 29, 2020
The Status of Specialized Ambulatory Heart Failure Care in Canada: A Joint Canadian Heart Failure Society and Canadian Cardiovascular Society Heart Failure Guidelines Survey
, Sean A Virani, Shelley Zieroth, et al.
The Canadian Journal of Cardiology
|
April 8, 2021
CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction
Michael McDonald, Sean Virani, Michael Chan, et al.
The Canadian Journal of Cardiology
|
February 11, 2020
CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis
Eileen O'Meara, Michael McDonald, Michael Chan, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 65) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 65 results.
The Canadian Journal of Cardiology
|
June 20, 2020
HEARTBiT: A Transcriptomic Signature for Excluding Acute Cellular Rejection in Adult Heart Allograft Patients
Casey P Shannon, Zsuzsanna Hollander, Darlene L Y Dai, et al.
The Canadian Journal of Cardiology
|
October 19, 2025
Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%)
Sean Virani, Shelley Zieroth, Natasha Aleksova, et al.
CJC Open
|
May 29, 2020
The Status of Specialized Ambulatory Heart Failure Care in Canada: A Joint Canadian Heart Failure Society and Canadian Cardiovascular Society Heart Failure Guidelines Survey
, Sean A Virani, Shelley Zieroth, et al.
The Canadian Journal of Cardiology
|
April 8, 2021
CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction
Michael McDonald, Sean Virani, Michael Chan, et al.
The Canadian Journal of Cardiology
|
February 11, 2020
CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis
Eileen O'Meara, Michael McDonald, Michael Chan, et al.
Page
of 7